The Clorox Company (NYSE:CLX) Stock Position Decreased by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky lowered its holdings in The Clorox Company (NYSE:CLX) by 5.9% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,256 shares of the company’s stock after selling 583 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Clorox were worth $1,508,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CLX. Mizuho Securities USA LLC lifted its holdings in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Van ECK Associates Corp lifted its stake in Clorox by 1,715.5% in the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after buying an additional 1,380,724 shares during the last quarter. Nuance Investments LLC boosted its holdings in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after acquiring an additional 960,094 shares during the period. Ilex Capital Partners UK LLP grew its position in shares of Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after acquiring an additional 453,624 shares during the last quarter. Finally, Wulff Hansen & CO. increased its holdings in shares of Clorox by 13,547.0% in the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock worth $60,063,000 after acquiring an additional 436,891 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE:CLX opened at $163.32 on Wednesday. The company has a 50-day moving average of $163.91 and a 200-day moving average of $152.34. The firm has a market cap of $20.22 billion, a price-to-earnings ratio of 56.91, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. Analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of analyst reports. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. BNP Paribas raised Clorox to a “strong sell” rating in a report on Friday, September 6th. Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Evercore ISI decreased their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Finally, Citigroup lifted their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Hold” and a consensus price target of $155.38.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.